Hunter Robert L, Actor Jefrey K, Hwang Shen-An, Khan Arshad, Urbanowski Michael E, Kaushal Deepak, Jagannath Chinnaswamy
Department of Pathology and Laboratory Medicine, University of Texas Health Sciences Center at Houston, Houston, TX 77030, USA.
Tulane National Primate Research Centre, Covington, LA 70433, USA.
Pathogens. 2018 Feb 6;7(1):19. doi: 10.3390/pathogens7010019.
Primary and post-primary tuberculosis (TB) are different diseases caused by the same organism. Primary TB produces systemic immunity. Post-primary TB produces cavities to support massive proliferation of organisms for transmission of infection to new hosts from a person with sufficient immunity to prevent systemic infection. Post-primary, also known as bronchogenic, TB begins in humans as asymptomatic bronchial spread of obstructive lobular pneumonia, not as expanding granulomas. Most lesions regress spontaneously. However, some undergo caseation necrosis that is coughed out through the necrotic bronchi to form cavities. Caseous pneumonia that is not expelled through the bronchi is retained to become the focus of fibrocaseous disease. No animal reproduces this entire process. However, it appears that many mammals utilize similar mechanisms, but fail to coordinate them as do humans. Understanding this makes it possible to use human tuberculous lung sections to guide manipulation of animals to produce models of particular human lesions. For example, slowly progressive and reactivation TB in mice resemble developing human bronchogenic TB. Similarly, bronchogenic TB and cavities resembling those in humans can be induced by bronchial infection of sensitized rabbits. Granulomas in guinea pigs have characteristics of both primary and post primary TB. Mice can be induced to produce a spectrum of human like caseating granulomas. There is evidence that primates can develop bronchogenic TB. We are optimistic that such models developed by coordinated study of human and animal tissues can be used with modern technologies to finally address long-standing questions about host/parasite relationships in TB, and support development of targeted therapeutics and vaccines.
原发性肺结核和继发性肺结核是由同一种病原体引起的不同疾病。原发性肺结核产生全身免疫力。继发性肺结核形成空洞,以支持病原体大量增殖,从而将感染从具有足够免疫力以预防全身感染的人传播给新宿主。继发性肺结核,也称为支气管源性肺结核,在人类中始于无症状的支气管播散性阻塞性小叶肺炎,而非扩展性肉芽肿。大多数病变会自发消退。然而,一些病变会发生干酪样坏死,通过坏死支气管咳出形成空洞。未通过支气管排出的干酪性肺炎会残留下来,成为纤维干酪性疾病的病灶。没有动物能重现这一完整过程。然而,似乎许多哺乳动物利用类似的机制,但不像人类那样进行协调。了解这一点使得利用人类结核性肺组织切片来指导对动物的操作,以产生特定人类病变的模型成为可能。例如,小鼠的缓慢进展性和再激活型肺结核类似于人类正在发展的支气管源性肺结核。同样,通过对致敏兔进行支气管感染,可以诱导出类似于人类的支气管源性肺结核和空洞。豚鼠的肉芽肿具有原发性和继发性肺结核的特征。可以诱导小鼠产生一系列类似人类的干酪样肉芽肿。有证据表明灵长类动物可以发展为支气管源性肺结核。我们乐观地认为,通过对人类和动物组织进行协同研究而开发的此类模型,可以与现代技术一起用于最终解决关于肺结核宿主/寄生虫关系的长期问题,并支持靶向治疗和疫苗的开发。